Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma

Clinical use of tumor biomarkers in prediction for prognosis and chemotherapeutic effect in esophageal squamous cell carcinoma

Abstract Background Growing evidence has indicated that tumor biomarkers, including cytokeratin 19 fragment antigen 21–1 (Cyfra21–1), carbohydrate antigen 19–9 (CA19–9), carbohydrate antigen 72–4 (CA72–4), carcinoembryonic antigen (CEA) and squamous cell carcinoma antigen (SCC-Ag) were reported to b...

Full description

Bibliographic Details
Main Authors: Yuchong Yang, Xuanzhang Huang, Likun Zhou, Ting Deng, Tao Ning, Rui Liu, Le Zhang, Ming Bai, Haiyang Zhang, Hongli Li, Yi Ba
Format: Article
Language:English
Published: BMC 2019-05-01
Series:BMC Cancer
Subjects:
Esophageal squamous cell carcinoma
Prognosis
Postoperative chemotherapy
Therapeutic effect; tumor biomarker
Online Access:http://link.springer.com/article/10.1186/s12885-019-5755-5

Internet

http://link.springer.com/article/10.1186/s12885-019-5755-5

Similar Items